Weight loss jab benefits vanish after stopping treatment
New research reveals weight returns quickly after stopping injections like Wegovy. Experts question NHS cost-effectiveness and highlight cheaper diet alternatives. Read the full analysis.
Category : Search result: NHS obesity treatment
Weight Loss Jabs: Experts Question Long-Term Value
New research reveals weight returns quickly after stopping injections like Wegovy. Experts warn of cost concerns for the NHS and suggest cheaper alternatives. Read the full analysis.
Weight Loss Jabs May Need Lifelong Use, Study Warns
New research reveals weight lost on injections like Wegovy is regained rapidly after stopping, raising NHS cost concerns. Discover if these treatments offer long-term value.
GLP-1 Drugs: Health Gains Reverse After Stopping, Study Finds
New research reveals that stopping weight-loss drugs like Ozempic leads to rapid weight regain and a reversal of heart health benefits, raising questions about their long-term role in obesity treatment. Read the full analysis.
Study: Stopping 'Skinny Jabs' Reverses Health Benefits
New research shows weight and key health markers like blood pressure and cholesterol rebound after ending GLP-1 drugs, raising questions about long-term use and holistic obesity care.
Weight Loss Jabs: Users Regain All Weight in 20 Months
A major Oxford University study reveals people on drugs like Wegovy and Mounjaro regain weight four times faster than traditional dieters after stopping. Learn the long-term implications for NHS policy and private users.
Study: Weight returns after stopping obesity jabs
A landmark Oxford review reveals weight regain is rapid after stopping GLP-1 drugs like Wegovy, suggesting a need for lifelong treatment. Experts warn of implications for NHS policy and private costs.
Weight-loss jabs may require lifelong use, study finds
A landmark Oxford review reveals weight returns rapidly after stopping GLP-1 drugs like Wegovy, suggesting a need for chronic treatment. Experts warn of NHS policy implications.
Genetics and Weight Loss: Why It's Harder for Some
Cambridge scientist Dr Giles Yeo explains how over 1,000 genes influence appetite and weight. Discover why willpower isn't the full story and what you can control.
Mutated 'Hunger Gene' Blocks Weight Loss, Expert Says
A Cambridge professor reveals a common gene mutation makes people feel constantly hungry, hindering weight loss. Discover the science and why new drugs offer hope.
UK bans unhealthy food ads to tackle childhood obesity
A landmark UK ban on TV and online ads for HFSS foods like sugary cereals and pizza is now in force. The government says it will prevent 20,000 childhood obesity cases. Read the full story.
Weight loss pills set for 2026 approval, cost to fall
A major shift in obesity treatment is coming as weight loss drugs in pill form are set for UK approval in 2026, making them cheaper and more accessible. Experts warn of the need for a public debate on long-term use.
Weight loss pills to become widely available in UK by 2026
A major shift in obesity treatment is coming as weight loss drugs in pill form are set for UK approval in 2026, promising wider access and lower costs. Experts warn a public debate is needed on long-term use.
World's most obese man dies aged 41 in Mexico
Juan Pedro Franco, once weighing 92 stone, has died from a kidney infection in Mexico aged 41. Read the full story on his health struggles and global obesity crisis.
Mum loses 13 stone after Christmas weight loss jab gift
Emily Murray, 35, shed over 13 stone after her dad bought her Mounjaro for Christmas. The Liverpool mum's transformation highlights the impact of new weight loss medications in the UK.
Pregnancy diet smell linked to child obesity risk
New research suggests the smell of fatty foods like bacon during pregnancy could predispose children to obesity. Learn about the study's findings and the implications for maternal nutrition.
Man denied NHS weight-loss surgery over ADHD
Keren Slater, 48, claims the NHS refused him a gastric bypass due to his ADHD, leaving him in limbo. He says he's being discriminated against and has nowhere to turn for help.
West Midlands tops UK childhood obesity chart
New NHS data exposes a growing health crisis as West Midlands records highest childhood obesity rates in England, with nearly 1 in 3 Year 6 children clinically obese.
Weight Loss Drug Showdown: Novo Nordisk vs Eli Lilly
The pharmaceutical weight loss market heats up as Novo Nordisk's blockbuster drugs Wegovy and Ozempic confront serious competition from Eli Lilly's Mounjaro, reshaping diabetes and obesity treatment landscapes.
UK Food Labels Failing in Obesity Fight, Study Reveals
Groundbreaking research exposes how current food labelling systems are failing British consumers and contributing to rising obesity rates across the UK.
England's Obesity Crisis Worsens: New Data Revealed
Exclusive analysis reveals England's escalating obesity epidemic with stark regional disparities and concerning patterns emerging across different demographic groups.
Model denied NHS cancer treatment in postcode lottery
Former model Sian Thompson's perfect life unravels as NHS refuses revolutionary cancer drug available privately, exposing Britain's healthcare postcode lottery crisis.
US Obesity Rates Hit Record High Amid New Drug Hope
New CDC data reveals American obesity rates have hit unprecedented levels, while revolutionary GLP-1 medications like Wegovy and Zepbound show promising results in combating the epidemic.
NHS stroke care revolution saves lives with faster treatment
Major NHS breakthrough sees stroke patients receiving life-saving treatment in record time, with new data showing dramatic improvements in recovery outcomes across England.
NHS approves weight loss drug Mounjaro
The groundbreaking diabetes treatment Mounjaro receives NHS approval for weight management, offering new hope for millions struggling with obesity in the UK.
NHS bosses warn of longer waiting times crisis
Exclusive: NHS leaders deliver sobering reality check to Rachel Reeves as new figures reveal growing treatment delays and funding shortfalls threatening patient care across Britain.
NHS forced to choose: Obesity crisis vs routine care
Exclusive analysis reveals how Britain's growing obesity epidemic is pushing the NHS toward an impossible choice between routine care and weight-related treatments as waiting lists hit record highs.
Wegovy's hidden mental benefits revealed
Stanford psychologist reveals how weight-loss drugs like Wegovy create profound mental changes that could revolutionise obesity treatment beyond mere physical transformation.
NHS waiting lists slashed by 206,000 patients
New figures reveal significant progress in reducing NHS waiting times with 206,000 fewer patients waiting for treatment, marking a major milestone in healthcare recovery.
NHS 10-minute robotic prostate surgery cuts waiting lists
Exclusive: British surgeons pioneer revolutionary robotic prostate procedures that take just 10 minutes, offering new hope for thousands stuck on NHS waiting lists. Discover how this medical breakthrough is transforming cancer care across the UK.
Page 1 of 4